Physician
P & S Clinic Ob-Gyn PLLC
P & S Clinic Ob-Gyn PLLC was paid $12.99M by Medicaid between Jan 2018 and Dec 2024, across 109 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoP & S CLINIC OB-GYN PLLC
AMORY, MS 38821
AMORY, MS 38821
33aNPI1538215546assigned 01/25/2007
33bProvider typeInternal Medicine Physician
28Total paid$12.99M
24GClaims312,054
24DCodes billed109
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Mississippi
Rank by total paid#1 of 139
Median peer was paid$26K
This provider vs. median499×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,122 | $1.58M | |
| 2019 | 40,952 | $1.76M | |
| 2020 | 42,552 | $1.81M | |
| 2021 | 59,584 | $2.44M | |
| 2022 | 60,753 | $2.43M | |
| 2023 | 44,012 | $1.89M | |
| 2024incomplete | 25,079 | $1.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 41,041 | 34,318 | $3.22M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 48,022 | 40,732 | $2.56M |
| 59426 | 8.8% | 13,259 | 6,519 | $1.14M | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.5% | 12,349 | 11,246 | $981K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.7% | 8,841 | 8,406 | $738K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5.6% | 10,647 | 8,245 | $734K |
| 59425 | 5.1% | 7,955 | 5,824 | $659K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.0% | 19,832 | 18,080 | $648K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.8% | 5,284 | 4,675 | $366K |
| 59410 | 1.6% | 365 | 301 | $205K | |
| 87634 | 1.3% | 3,198 | 2,856 | $175K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 5,411 | 4,899 | $167K |
97 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 12,331 | $155K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,317 | $110K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13,171 | $101K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,166 | $94K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 2,667 | $93K |
| 99460 | <1% | 1,088 | $81K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,182 | $68K |
| D1206 | Topical application of fluoride varnish | <1% | 2,620 | $60K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,578 | $52K |
| 87430 | <1% | 4,028 | $47K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,050 | $45K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 838 | $43K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,536 | $41K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,189 | $39K |
| 99219 | <1% | 426 | $39K | |
| 90461 | <1% | 13,892 | $31K | |
| 76830 | Ultrasound, transvaginal | <1% | 481 | $28K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 232 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 517 | $19K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 277 | $18K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 192 | $18K |
| 90837 | Psychotherapy session, about an hour | <1% | 177 | $15K |
| 59515 | <1% | 15 | $12K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 734 | $12K |
| 81025 | <1% | 2,368 | $12K | |
| 92551 | <1% | 1,272 | $10K | |
| 99462 | <1% | 294 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 107 | $10K |
| 96127 | <1% | 4,295 | $10K | |
| 76857 | <1% | 363 | $9K | |
| 87807 | <1% | 691 | $9K | |
| 87400 | <1% | 423 | $8K | |
| 96161 | <1% | 5,566 | $8K | |
| 76801 | <1% | 79 | $7K | |
| 90670 | <1% | 7,792 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 338 | $6K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 272 | $6K |
| 99223 | Prolong inpt eval add15 m | <1% | 27 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 327 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 365 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,576 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 100 | $4K |
| 99401 | <1% | 170 | $3K | |
| 74018 | <1% | 157 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 48 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 63 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 65 | $2K |
| 99173 | <1% | 969 | $2K | |
| 98926 | <1% | 68 | $2K | |
| 99459 | <1% | 349 | $2K | |
| 59200 | <1% | 164 | $2K | |
| 90677 | <1% | 972 | $1K | |
| 90686 | <1% | 4,258 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 18 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 37 | $1K |
| 59025 | Fetal non-stress test | <1% | 72 | $948.55 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 73 | $906.57 |
| 81002 | <1% | 338 | $817.32 | |
| 59430 | <1% | 424 | $775.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,733 | $671.08 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 77 | $507.54 |
| 69210 | <1% | 14 | $433.20 | |
| 90648 | <1% | 8,897 | $364.40 | |
| 99051 | <1% | 14 | $310.00 | |
| 90716 | <1% | 597 | $282.00 | |
| 96380 | <1% | 12 | $217.20 | |
| 90707 | <1% | 584 | $163.33 | |
| 90671 | <1% | 48 | $144.00 | |
| 86308 | <1% | 17 | $77.85 | |
| 99307 | <1% | 37 | $63.72 | |
| 90696 | <1% | 311 | $55.82 | |
| 90656 | <1% | 157 | $50.16 | |
| 87210 | <1% | 16 | $40.32 | |
| 80305 | <1% | 18 | $34.63 | |
| 90700 | <1% | 479 | $30.75 | |
| 90633 | <1% | 2,328 | $10.54 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 22 | $4.80 |
| J3490 | Unclassified drugs | <1% | 505 | $0.49 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 217 | $0.05 |
| 90723 | <1% | 6,885 | $0.04 | |
| 90710 | 0% | 290 | $0.00 | |
| 90681 | 0% | 2,907 | $0.00 | |
| 90380 | 0% | 103 | $0.00 | |
| 90734 | 0% | 30 | $0.00 | |
| 90685 | 0% | 42 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 51 | $0.00 |
| 90680 | 0% | 1,551 | $0.00 | |
| G9231 | Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period | 0% | 1,118 | $0.00 |
| 99024 | 0% | 461 | $0.00 | |
| 90381 | 0% | 17 | $0.00 | |
| G8708 | Patient not prescribed antibiotic | 0% | 851 | $0.00 |
| 91307 | 0% | 18 | $0.00 | |
| 90651 | 0% | 106 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 45 | $0.00 |
| G9459 | Currently a tobacco non-user | 0% | 21 | $0.00 |
| 94760 | 0% | 14 | $0.00 | |
| 99000 | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAGELY, MICHELLE (PROVIDER ENROLLMENT)